Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Rugo HS, Pluard TJ, Sharma P, Melisko M, et al. OPERA: a phase II study of DHP107 (oral paclitaxel) versus intravenous paclitaxel in patients with HER2-negative recurrent or metastatic breast cancer. Breast Cancer Res Treat 2026;217:5.
PMID: 41910867


Privacy Policy